투자판단관련주요경영사항(임상시험계획변경승인) (뎅기 또는 뎅기 유사 질환 환자를 대상으로 CPCOV03의 2/3상 임상시험계획 변경승인)[코]
Received: 11/12/2025 · Reporter: 현대바이오
A summary for this filing type is not yet available. Please refer to the original DART filing.
🏢 Past 12 months filing pattern (this company)
- Total filings
- 30 filings
- Same category
- 9 filings
- Previous same-category filing
- 6/23/2026
- Corrections / withdrawals
- 1 filing
Filing source / License
The original PDF/HTML of this filing is provided by FSS DART. MarketBubbles displays only metadata (title, receipt number, type, reporter) and a rule-based summary; we do not mirror the original PDF body (per FSS ToS).